跳至主要内容
临床试验/NCT06985992
NCT06985992尚未招募不适用

The Efficacy of Intrathecal Morphine Versus Intrathecal Morphine-Dexamethasone Combination in Cesarean Delivery: A Prospective Randomized Double-Blind Clinical Trial

Yuzuncu Yıl University0 个研究点目标入组 120 人开始时间: 2025年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
主要终点
Postoperative nausea-vomiting

研究概览

简要总结

The Efficacy of Intrathecal Morphine Versus Intrathecal Morphine+Dexamethasone Combination added to bupivacaine in elective cesarean section under spinal anesthesia

详细描述

The study will be designed as a double-blind, randomized clinical trial and will be conducted following approval by the local ethics committee. A total of 120 patients, aged 18-40 years, with an ASA physical status of II and scheduled for elective cesarean section, will be included. All patients will undergo standard preparation for spinal anesthesia. Two large-bore intravenous lines will be inserted in each patient upon arrival in the operating room. Participants will be randomly assigned to one of two groups (n = 60 per group) using sealed opaque envelopes.

Group I (morphine group) will receive spinal anesthesia consisting of 2 mL (10 mg) bupivacaine, 0.1 mL (100 mcg) morphine, and 0.5 mL saline.

Group II (morphine+dexamethasone group) will receive a mixture of 2 mL (10 mg) bupivacaine, 0.1 mL (100 mcg) morphine, and 0.5 mL (2 mg) dexamethasone.

Intraoperative hemodynamic parameters (including age, height, and weight), ASA scores, postoperative complications (such as nausea, vomiting, and pruritus), and postoperative pain levels will be recorded and analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Patients scheduled for caesarean sections
  • •Between 18-40 years
  • •ASA II group
  • •Those who will undergo spinal anesthesia
  • •Those between 35-40 weeks of pregnancy
  • •1st and 2nd caesarean sections

排除标准

  • •Those who prefer general anesthesia
  • •Those who are outside the age range of 18-40
  • •Those who are ASA III and above
  • •Those with HT, DM, cardiac and respiratory diseases
  • •Preeclampsia, eclampsia, HELLP
  • •Those with a history of drug use that affects the cardiovascular system
  • •Placenta Previa, Placenta Acreta, Placenta Acreta Those with a history of antiemetic or antidepressant drug use

研究组 & 干预措施

Group morfin+dexamethasone

Experimental

Group morfin+dexamethasone: Spinal anesthesia will be applied to patients who will undergo a caesarean section using a combination of 2 ml (10 mg) bupivacaine + 0.1 ml (100 mcg) morphine + 0.5 ml (2 mg) dexamethasone.

干预措施: Group morfin+dexamethasone (Procedure)

Group morfin

Active Comparator

Group Morphine: Spinal anesthesia will be applied to patients who will undergo caesarean section using a combination of 2 ml (10 mg) bupivacaine + 0.1 ml (100 mcg) morphine + 0.5 ml saline.

干预措施: Group morphine (Procedure)

结局指标

主要结局

Postoperative nausea-vomiting

时间窗: For 24 hours after surgery

The incidence of postoperative nausea and vomiting will be scored from 0 to 3. No nausea or vomiting attacks will be graded as 0, a nausea attack that resolves without treatment will be graded as 1, recurrent nausea attacks that resolve with treatment will be graded as 2, and persistent nausea or vomiting attacks will be graded as 3.

Postoperative itching

时间窗: For 24 hours after surgery

The degree of pruritus will be assessed on a scale of 0 to 3, with 0 being categorized as no pruritus; 1 as mild pruritus; 2 as moderate pruritus; and 3 as severe pruritus.

次要结局

  • Intraoperative Mean Blood Pressure(Intraoperatively every 5 minutes)
  • Intraoperative Heart Rate(Intraoperatively every 5 minutes)

研究者

发起方
Yuzuncu Yıl University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nurettin KURT

Assistant Professor

Yuzuncu Yıl University

相似试验